Guidance For Industry Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects
Contains Nonbinding Recommendations
TABLE OF CONTENTS
I. INTRODUCTION
II. OVERVIEW OF INVESTIGATOR RESPONSIBILITIES
III. CLARIFICATION OF CERTAIN INVESTIGATOR RESPONSIBILITIES
A. SUPERVISION OF THE CONDUCT OF A CLINICAL INVESTIGATION
1. What Is Appropriate Delegation of Study-Related Tasks?
2. What Is Adequate Training?
3. What Is Adequate Supervision of the Conduct of an Ongoing Clinical Trial?
4. What Are an Investigator’s Responsibilities for Oversight of Other Parties Involved in the Conduct of a Clinical Trial?
B. PROTECTING THE RIGHTS, SAFETY, AND WELFARE OF STUDY SUBJECTS.
1. Reasonable Medical Care Necessitated by Participation in a Clinical Trial.
2. Reasonable Access to Medical Care.
3. Protocol Violations that Present Unreasonable Risks.
ATTACHMENT A: COPY OF FORM 1572.
ATTACHMENT B: INVESTIGATOR RESPONSIBILITIES.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Additional copies are available from:
Office of Training and Communication
Division of Drug Information, HFD-240
Center for Drug Evaluation and Research
Food and Drug Administration
(Tel) 301-827-4573
http://www.fda.gov/cder/guidance/index.htm or
Office of Communication, Training and Manufacturers Assistance, HFM-40
Center for Biologics Evaluation and Research
Food and Drug Administration
http://www.fda.gov/cber/guidelines.htm (Tel) 800-835-4709 or 301-827-1800 or
Office of Health and Industry Programs
Division of Small Manufacturers, International, and Consumer Assistance, HFZ-220
Center for Devices and Radiological Health
Food and Drug Administration
Tel: 1-800-638-2041
http://www.fda.gov/cdrh U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Procedural
October 2009
Clinical Research News
Kommende kliniske forsøg
-
NCT04840316Ikke rekrutteret endnuBetingelser: Delirum; Complication,Postoperative
-
NCT04840329RekrutteringBetingelser: Endometriosis
-
NCT04840342Ikke rekrutteret endnuBetingelser: Hypertension; Mineralocorticoid Excess
-
NCT04840368Ikke rekrutteret endnuBetingelser: Aging; Type2 Diabetes
-
NCT04840394Ikke rekrutteret endnuBetingelser: Tumor, Solid
-
NCT04840420Ikke rekrutteret endnuBetingelser: Social Isolation
-
NCT04840485Ikke rekrutteret endnuBetingelser: Ankylosing Spondylitis
-
NCT04840589Ikke rekrutteret endnuBetingelser: Metastatic Malignant Solid Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Platinum-Resistant Ovarian Carcinoma; Refractory Ovarian Carcinoma
-
NCT04840602Ikke rekrutteret endnuBetingelser: Lymphoplasmacytic Lymphoma; Waldenstrom Macroglobulinemia
-
NCT04840615RekrutteringBetingelser: Mesothelioma
Recent CRA jobs
-
Sr Document Review Spec
-
Ctry Approval Associate
-
Start Up CRA
-
(Sr) Site Contract Specialist - France
-
Project & Budget Analyst - UK
-
Project Specialist I - Inside Sales ; AES
-
AD Biostatistics (remote or office)
-
Sr Mgr Pharmacokinetics - Europe
-
Biostatistics Dir (remote or office)
-
Programming Dir (remote or office)